• Something wrong with this record ?

Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome

T. Roubicek, J. Stros, P. Kucera, P. Nedbal, J. Cerny, R. Polasek, D. Wichterle,

. 2019 ; 14 (7) : e0219966. [pub] 20190717

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc20006142

INTRODUCTION: The aim of this study was to investigate the predictors of long-term clinical outcome of heart failure (HF) patients who survived first year after initiation of cardiac resynchronization therapy (CRT). METHODS: This was a single-center observational cohort study of CRT patients implanted because of symptomatic HF with reduced ejection fraction between 2005 and 2013. Left ventricle (LV) diameters and ejection fraction, New York Heart Association (NYHA) class, and level of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) were assessed at baseline and 12 months after CRT implantation. Their predictive power for long-term HF hospitalization and mortality, and cardiac and all-cause mortality was investigated. RESULTS: A total of 315 patients with left bundle branch block or intraventricular conduction delay who survived >1 year after CRT implantation were analyzed in the current study. During a follow-up period of 4.8±2.1 years from CRT implantation, 35.2% patients died from cardiac (19.3%) or non-cardiac (15.9%) causes. Post-CRT LV ejection fraction and LV end-systolic diameter (either 12-month value or the change from baseline) were equally predictive for clinical events. For NT-proBNP, however, the 12-month level was a stronger predictor than the change from baseline. Both reverse LV remodeling and 12-month level of NT-proBNP were independent and comparable predictors of CRT-related clinical outcome, while NT-proBNP response had the strongest association with all-cause mortality. When post-CRT relative change of LV end-systolic diameter and 12-month level of NT-proBNP (dichotomized at -12.3% and 1230 ng/L, respectively) were combined, subgroups of very-high and very-low risk patients were identified. CONCLUSION: The level of NT-proBNP and reverse LV remodeling at one year after CRT are independent and complementary predictors of future clinical events. Their combination may help to improve the risk stratification of CRT patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006142
003      
CZ-PrNML
005      
20200518132350.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0219966 $2 doi
035    __
$a (PubMed)31314790
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Roubicek, Tomas $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic. Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Faculty of Health Studies, Technical University of Liberec, Liberec, Czech Republic.
245    10
$a Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome / $c T. Roubicek, J. Stros, P. Kucera, P. Nedbal, J. Cerny, R. Polasek, D. Wichterle,
520    9_
$a INTRODUCTION: The aim of this study was to investigate the predictors of long-term clinical outcome of heart failure (HF) patients who survived first year after initiation of cardiac resynchronization therapy (CRT). METHODS: This was a single-center observational cohort study of CRT patients implanted because of symptomatic HF with reduced ejection fraction between 2005 and 2013. Left ventricle (LV) diameters and ejection fraction, New York Heart Association (NYHA) class, and level of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) were assessed at baseline and 12 months after CRT implantation. Their predictive power for long-term HF hospitalization and mortality, and cardiac and all-cause mortality was investigated. RESULTS: A total of 315 patients with left bundle branch block or intraventricular conduction delay who survived >1 year after CRT implantation were analyzed in the current study. During a follow-up period of 4.8±2.1 years from CRT implantation, 35.2% patients died from cardiac (19.3%) or non-cardiac (15.9%) causes. Post-CRT LV ejection fraction and LV end-systolic diameter (either 12-month value or the change from baseline) were equally predictive for clinical events. For NT-proBNP, however, the 12-month level was a stronger predictor than the change from baseline. Both reverse LV remodeling and 12-month level of NT-proBNP were independent and comparable predictors of CRT-related clinical outcome, while NT-proBNP response had the strongest association with all-cause mortality. When post-CRT relative change of LV end-systolic diameter and 12-month level of NT-proBNP (dichotomized at -12.3% and 1230 ng/L, respectively) were combined, subgroups of very-high and very-low risk patients were identified. CONCLUSION: The level of NT-proBNP and reverse LV remodeling at one year after CRT are independent and complementary predictors of future clinical events. Their combination may help to improve the risk stratification of CRT patients.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $7 D015415
650    _2
$a srdeční resynchronizační terapie $x škodlivé účinky $x metody $7 D058406
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x metabolismus $x mortalita $x patologie $x terapie $7 D006333
650    _2
$a funkční vyšetření srdce $7 D006334
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretický peptid typu B $x metabolismus $7 D020097
650    _2
$a pooperační období $7 D011184
650    _2
$a prognóza $7 D011379
650    _2
$a ROC křivka $7 D012372
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    12
$a remodelace komor $7 D020257
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stros, Jan $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic.
700    1_
$a Kucera, Pavel $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic.
700    1_
$a Nedbal, Pavel $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic.
700    1_
$a Cerny, Jan $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic.
700    1_
$a Polasek, Rostislav $u Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic. Faculty of Health Studies, Technical University of Liberec, Liberec, Czech Republic.
700    1_
$a Wichterle, Dan $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Faculty of Health Studies, Technical University of Liberec, Liberec, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 7 (2019), s. e0219966
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31314790 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132349 $b ABA008
999    __
$a ok $b bmc $g 1525000 $s 1096198
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 7 $d e0219966 $e 20190717 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Archiving options